Mumbai-based ENTOD Pharmaceuticals has taken steps to address concerns raised by the Drug Controller General of India (DCGI) regarding its newly approved PresVu eye drops, intended for the treatment of presbyopia in adults. The leadership team of ENTOD met with the DCGI earlier this week,
Entod Pharmaceuticals has announced that it has received final approval from the Drug Controller General of India (DCGI) for its groundbreaking PresVu eye drops. This approval, disclosed during a press conference held today in New Delhi, follows a favorable recommendation by the Subject Expert Committee
